The clinical value of non-curative resection followed by chemotherapy for incurable gastric cancer. (Q47979452)

7 February 2018

title

The clinical value of non-curative resection followed by chemotherapy for incurable gastric cancer. (English)

1 reference

7 February 2018

1 reference

Kyung Jai Ko

1

1 reference

7 February 2018

Jung Ho Shim

2

1 reference

7 February 2018

Han Mo Yoo

3

1 reference

7 February 2018

Seong Il O

4

1 reference

7 February 2018

Hae Myung Jeon

5

1 reference

7 February 2018

Cho Hyun Park

6

1 reference

7 February 2018

Dong Jin Jeon

7

1 reference

7 February 2018

Kyo Young Song

8

1 reference

7 February 2018

publication date

1 August 2012

1 reference

7 February 2018

published in

World Journal of Surgery

1 reference

7 February 2018

volume

36

1 reference

7 February 2018

issue

8

1 reference

7 February 2018

page(s)

1800-1805

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1007/s00268-012-1566-4

exact match

0 references

cites work

Treatment results for gastric cancer surgery: 12 years' experience at a single institute in Korea.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1566-4

Decision making on surgical palliation based on patient outcome data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1566-4

Palliative resection in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1566-4

Therapeutic significance of palliative operations for gastric cancer for survival and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1566-4

Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1566-4

Cancer-induced immunosuppression: implications for therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1566-4

Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1566-4

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1566-4

The development of a method for assessing the quality of life of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1566-4

Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1566-4

Cancer pain relief and palliative care. Report of a WHO Expert Committee

21 January 2018

1 reference

12 December 2020

The survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience. Norwegian Stomach Cancer Trial

1 reference

12 December 2020

Prognosis of patients after palliative surgical procedures for carcinoma of the stomach.

1 reference

12 December 2020

Total gastrectomy for advanced cancer. A worthwhile palliative procedure

1 reference

12 December 2020

Role for surgical cytoreduction in multimodality treatments for cancer

1 reference

12 December 2020

10.1007/S00268-012-1566-4

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

22450753

1 reference

7 February 2018